|
|
|
|
|
|
|
|
|
22.08.25 - 10:15
|
Full-day Takeaway: HSI Closes at 25,339, Up 234 pts; HSTI Closes at 5,647, Up 149 pts; XPENG Up over 13%; TENCENT, SINO BIOPHARM, CHOW TAI FOOK, CHINA MOBILE, HUA HONG SEMI Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 234 pts or 0.9% to 25,339. HSTI rose 149 pts or 2.7% to 5,647. HSCEI gained 105 pts or 1.2% to 9,079. Market turnover reached $285.58 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $52.55, up 2.3%BABA (09988.HK) closed at $118, up 2%HKEX (00388.HK) closed at $448, up 1.3%TENCENT (00700.HK) closed at $......
|
|
|
22.08.25 - 06:15
|
Midday Takeaway: HSI Closes Midday at 25,184, Up 80 pts; HSTI Closes Midday at 5,586, Up 88 pts; XPENG Up over 10%; TENCENT, SINO BIOPHARM, CHOW TAI FOOK, HUA HONG SEMI, AKESO Hit New Highs (AAStocks)
|
|
|
At midday close, HSI rose 80 pts or 0.3% to 25,184. HSTI rose 88 pts or 1.6% to 5,586. HSCEI gained 47 pts or 0.5% to 9,022.Active Heavyweights:XIAOMI (01810.HK) closed at $52.35, up 1.9%TENCENT (00700.HK) closed at $601.5, up 1.4%, hitting new highBABA (09988.HK) closed at $117.2, up 1.3%MEITUAN (03690.HK) closed at $116.6, dow......
|
|
|
22.08.25 - 05:30
|
Research: M Stanley Lists Latest HK Focus List (Table) (AAStocks)
|
|
|
StockAlibaba Group Holding (BABA.US)CHINA RES POWER (00836.HK)YANGTZE POWER (600900.SH)CATL (300750.SZ)* DUALITYBIO-B (09606.HK)ESPRESSIF (688018.SH)HKT-SS (06823.HK)HKEX (00388.HK)NARI (600406.SH)PETROCHINA (00857.HK)PICC P&C (02328.HK)SPRING AIRLINES (601021.SH)SUNNY OPTICAL (02382.HK)TENCENT (00700.HK)ZIJIN MINING (02899.......
|
|
|
22.08.25 - 02:06
|
China′s rise in biotech could lower healthcare costs, investor says (SCMP)
|
|
|
China's rise in biotech innovation offers the world a potentially cheaper alternative to costly healthcare products from Western suppliers, but geopolitical tensions remain a major challenge for the country's globalisation efforts, according to a local investor in the sector.
“We can lower the cost of healthcare and benefit more people through technological innovation and efficiency improvement,” Da Liu, managing director of CR-CP Life Science Fund, said in an interview with the Post earlier......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 08:18
|
CanSino Says Close to Break Even This Year (Bloomberg)
|
|
|
Xuefeng Yu, co-Founder, chairman and CEO of Chinese vaccine maker CanSino Biologics, says he expects the company's newly approved pneumococcal vaccine to help boost revenue next in 2026. Still, he adds that the firm is on track to reach its breakeven target this year. He speaks exclusively with David Ingles and Yvonne Man on "Bloomberg: The China Show." (Source: Bloomberg)...
|
|
|
|
|
|
|
21.08.25 - 05:00
|
Research: Citi Raises WUXI BIO TP to $40 as Rev. Growth Accelerates (AAStocks)
|
|
|
WUXI BIO (02269.HK)'s management raised its revenue growth guidance from 12-15% YoY to 14-16%, primarily due to the rapid growth of early-stage research projects and late-stage CMO projects, Citi Research issued a research report saying. The Group's production projects maintained growth momentum, with the guidance for PP......
|
|
|
21.08.25 - 05:00
|
Research: CLSA Elevates WUXI XDC TP to $70.7, Reaffirms Rating at Outperform (AAStocks)
|
|
|
WUXI XDC (02268.HK)'s 1H25 revenue/ adjusted net profit grew by 62%/ 50% YoY, in line with previous profit alert, CLSA published a research report saying. Driven by strong demand in the US market, total backlog and new orders during the period increased by 58% and 48% YoY respectively.CLSA held a long-term positive view on W......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
